Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.4 Assumptions
Chapter 2 Executive Summary
2.1 Global STD Market Portraiture
2.2 Global STD Market, by Treatment Type, 2017 (US$ Mn)
2.3 Global STD Market, by Geography, 2017 (US$ Mn)
Chapter 3 Global Sinusitis Treatment Drugs (STD) Market Analysis
3.1 Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 High Prevalence of Sinusitis
3.2.1.2 Rising Pollution Contributing to Increased Incidence of Sinusitis
3.2.2 Challenges
3.2.2.1 Overuse of Drugs and Excessive Self Medication
3.2.3 Market Opportunities
3.2.3.1 Big Opportunities for New Innovative Treatments
3.3 Attractive Investment Proposition, by Geography, 2017
3.4 Market Positioning: by Key Players in STD Market, 2016
Chapter 4 Global Sinusitis Treatment Drugs (STD) Market, by Treatment Type, 2018-2026 (US$ Mn)
4.1 Overview
4.2 Antibiotics
4.2.1 Cephalosporin Antibiotics
4.2.2 Penicillin/Beta Lactamase Inhibitors
4.2.3 Macrolide Antibiotics
4.2.4 Quinolone Antibiotics
4.3 NSAIDS
4.4 Decongestant & Mucolytic
4.4.1 Imidazoline Derivatives
4.4.2 Antihistamines
4.4.3 Corticosteroids
4.4.4 α₁-adrenergic receptor agonist
4.5 Nasal Irrigation Kits
4.6 Pipeline Analysis
4.6.1 Phase III
4.6.1.1 Omalizumab (F.Hoffman La-Roche AG)
4.6.2 Phase II and I (Tabular Format)
Chapter 5 Global Sinusitis Treatment Drugs (STD) Market, by Geography, 2016–2026 (US$ Mn)
5.1 Overview
5.2 North America
5.2.1 North America STD Market, by Treatment Type, 2016–2026 (US$ Mn)
5.2.2 North America STD Market, by Country, 2016–2026 (US$ Mn)
5.2.2.1 U.S.
5.2.2.2 Canada
5.3 Europe
5.3.1 Europe STD Market, by Treatment Type, 2016–2026 (US$ Mn)
5.3.2 Europe STD Market, by Region/Country, 2016–2026 (US$ Mn)
5.3.2.1 U.K.
5.3.2.2 Germany
5.3.2.3 Rest of Europe
5.4 Asia Pacific
5.4.1 Asia Pacific STD Market, by Treatment Type, 2016–2026 (US$ Mn)
5.4.2 Asia Pacific STD Market, by Region/Country, 2016–2026 (US$ Mn)
5.4.2.1 Japan
5.4.2.2 China
5.4.2.3 Rest of Asia Pacific
5.5 Latin America (LATAM)
5.5.1 Latin America STD Market, by Treatment Type, 2016–2026 (US$ Mn)
5.5.2 Latin America STD Market, by Region/Country, 2016–2026 (US$ Mn)
5.5.2.1 Brazil
5.5.2.2 Mexico
5.5.2.3 Rest of Latin America
5.6 Middle East & Africa (MEA)
5.6.1 Middle East & Africa STD Market, by Treatment Type, 2016–2026 (US$ Mn)
5.6.2 Middle East & Africa STD Market, by Region, 2016–2026 (US$ Mn)
5.6.2.1 GCC
5.6.2.2 Rest of Middle East & Africa
Chapter 6 Company Profiles
6.1 Pfizer, Inc.
6.2 Abbott Laboratories, Inc.
6.3 Janssen Pharmaceuticals, Inc.
6.4 GlaxoSmithkline, Plc.
6.5 Sanofi SA
6.6 Sandoz International GmbH (a subsidiary of Novartis International AG)
6.7 Bayer AG
6.8 Merck & Co., Inc.
6.9 Sun Pharmaceutical Industries Ltd.
6.10 Teva Pharmaceutical Industries Ltd.
List of Figures
FIG. 1 Research Methodology: Global Sinusitis Treatment Drugs (STD) Market
FIG. 2 Global STD Market, by Treatment Type, 2017 (US$ Mn)
FIG. 3 Global STD Market, by Geography, 2017 (US$ Mn)
FIG. 4 Classification of Adult Rhinosinusitis
FIG. 5 Attractive Investment Proposition: Global STD Market, by Geography, 2017
FIG. 6 Market Positioning of Key Players in STD Market, 2017
FIG. 7 Global Cephalosporin Antibiotics Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 8 Global Penicillin/Beta Lactamase Inhibitors Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 9 Global Macrolide Antibiotics Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 10 Global Quinolone Antibiotics Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 11 Global NSAIDS Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 12 Global Imidazoline Derivatives Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 13 Global Antihistamines Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 14 Global Corticosteroids Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 15 Global A₁-adrenergic Receptor Agonist Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 16 Global Nasal Irrigation Kits Market for Sinusitis Treatment, 2016-2026 (US$ Mn)
FIG. 17 U.S. STD Market, 2016–2026 (US$ Mn)
FIG. 18 Canada STD Market, 2016–2026 (US$ Mn)
FIG. 19 U.K. STD Market, 2016–2026 (US$ Mn)
FIG. 20 Germany STD Market, 2016–2026 (US$ Mn)
FIG. 21 Rest of Europe STD Market, 2016–2026 (US$ Mn)
FIG. 22 Japan STD Market, 2016–2026 (US$ Mn)
FIG. 23 China STD Market, 2016–2026 (US$ Mn)
FIG. 24 Rest of Asia Pacific STD Market, 2016–2026 (US$ Mn)
FIG. 25 Brazil STD Market, 2016–2026 (US$ Mn)
FIG. 26 Mexico STD Market, 2016–2026 (US$ Mn)
FIG. 27 Rest of Latin America STD Market, 2016–2026 (US$ Mn)
FIG. 28 GCC STD Market, 2016–2026 (US$ Mn)
FIG. 29 Rest of Middle East & Africa STD Market, 2016–2026 (US$ Mn)
List of Tables
TABLE 1 Global Sinusitis Treatment Drugs (STD) Market Portraiture
TABLE 2 Global STD Market, by Treatment Type, 2016–2026 (US$ Mn)
TABLE 3 Global Antibiotics Market for Sinusitis Treatment, 2016–2026 (US$ Mn)
TABLE 4 Global Decongestant & Mucolytic Market for Sinusitis Treatment, 2016–2026 (US$ Mn)
TABLE 5 Global STD Market, by Geography, 2016–2026 (US$ Mn)
TABLE 6 North America STD Market, by Treatment Type, 2016–2026 (US$ Mn)
TABLE 7 North America STD Market, by Country, 2016–2026 (US$ Mn)
TABLE 8 Europe STD Market, by Treatment Type, 2016–2026 (US$ Mn)
TABLE 9 Europe STD Market, by Region/Country, 2016–2026 (US$ Mn)
TABLE 10 Asia Pacific STD Market, by Treatment Type, 2016–2026 (US$ Mn)
TABLE 11 Asia Pacific STD Market, by Region/Country, 2016–2026 (US$ Mn)
TABLE 12 Latin America STD Market, by Treatment Type, 2016–2026 (US$ Mn)
TABLE 13 Latin America STD Market, by Region/Country, 2016–2026 (US$ Mn)
TABLE 14 Middle East & Africa STD Market, by Treatment Type, 2016–2026 (US$ Mn)
TABLE 15 Middle East & Africa STD Market, by Region, 2016–2026 (US$ Mn)
TABLE 16 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 18 Jansenn Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 19 GlaxoSmithkline, Plc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 20 Sanofi SA: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 21 Sandoz International GmbH (a subsidiary of Novartis International AG): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Bayer AG: Company Snapshot (Business Description; Financial Performance; Product Portfolio; Key Developments)
TABLE 23 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; Key Developments)
TABLE 24 Sun Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; Key Developments)
TABLE 25 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; Key Developments)